Kevin Dondarski

Kevin is a Partner within Deloitte Consulting’s life sciences strategy practice with a focus on Research & Development (R&D). Kevin partners with organizations’ senior leadership to deliver innovative and implementable strategies to improve R&D productivity. He has over 20 years of Life Sciences experience and has broad expertise spanning across drug discovery and development, clinical operations, regulatory affairs, and portfolio management.

Prior to joining Deloitte, Kevin worked for Wyeth as a biopharmaceutical research engineer supporting the discovery, development and commercialization of various monoclonal antibody conjugate and vaccine programs. Kevin received a B.S. in Biochemical Engineering from Rutgers University, an M.S. in Chemical Engineering from Rutgers University, and an M.B.A. in Finance and Managerial Economics from the Kellogg School of Management at Northwestern University.